The Japanese government is aiming to reduce the country’s reliance on foreign-made vaccines. It’s ramping up funding for domestic development to better prepare for future coronavirus outbreaks and other epidemics.
The plan is to help drug makers install dual-use facilities that can easily be switched from producing biopharmaceuticals to vaccines when needed.
Officials say they will subsidize 90 percent of the investment’s cost.
The government will also help set up hubs dedicated to making vaccines. It plans to cover three-quarters of the costs for small and medium-sized businesses, and slightly less for large firms.
Officials are funding the effort with about 2.4 billion dollars in their draft supplementary budget for the current fiscal year.